<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1195873</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2023.1195873</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Oxygen-saturation-related functional parameter as a biomarker for diabetes mellitus&#x2014;extraction method and clinical validation</article-title>
<alt-title alt-title-type="left-running-head">Zhang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2023.1195873">10.3389/fcell.2023.1195873</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jinze</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2208415/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Zhongzhou</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Gengyuan</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1454549/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Yuancong</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fei</surname>
<given-names>Keyi</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yushuang</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Jiaxiong</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yuan</surname>
<given-names>Jin</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1322406/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xiao</surname>
<given-names>Peng</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1357919/overview"/>
</contrib>
</contrib-group>
<aff>
<institution>State Key Laboratory of Ophthalmology</institution>, <institution>Zhongshan Ophthalmic Center</institution>, <institution>Sun Yat-sen University</institution>, <institution>Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science</institution>, <institution>Guangdong Provincial Clinical Research Center for Ocular Diseases</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1439952/overview">Weihua Yang</ext-link>, Jinan University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1511625/overview">Bilian Ke</ext-link>, Shanghai General Hospital, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1824701/overview">Gangjin Kang</ext-link>, The Affiliated Hospital of Southwest Medical University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1033526/overview">Fan Li</ext-link>, Zhongshan People&#x2019;s Hospital (ZSPH), China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jin Yuan, <email>yuanjincornea@126.com</email>; Peng Xiao, <email>xiaopengaddis@hotmail.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1195873</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>03</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>05</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Zhang, Luo, Wang, Huang, Fei, Liu, Li, Yuan and Xiao.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Zhang, Luo, Wang, Huang, Fei, Liu, Li, Yuan and Xiao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Purpose:</bold> To develop a computational method for oxygen-saturation-related functional parameter analysis of retinal vessels based on traditional color fundus photography, and to explore their characteristic alterations in type 2 diabetes mellitus (DM).</p>
<p>
<bold>Methods:</bold> 50 type 2 DM patients with no-clinically detectable retinopathy (NDR) and 50 healthy subjects were enrolled in the study. An optical density ratio (ODR) extraction algorithm based on the separation of oxygen-sensitive and oxygen-insensitive channels in color fundus photography was proposed. With precise vascular network segmentation and arteriovenous labeling, ODRs were acquired from different vascular subgroups, and the global ODR variability (ODR<sub>v</sub>) was calculated. Student&#x2019;s t-test was used to analyze the differences of the functional parameters between groups, and regression analysis and receiver operating characteristic (ROC) curves were used to explore the discrimination efficiency of DM patients from healthy subjects based on these functional parameters.</p>
<p>
<bold>Results:</bold> There was no significant difference in the baseline characteristics between the NDR and healthy normal groups. The ODRs of all vascular subgroups except the micro venule were significantly higher (<inline-formula id="inf1">
<mml:math id="m1">
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>&#x3c;</mml:mo>
<mml:mn>0.05</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>, respectively) while ODR<sub>v</sub> was significantly lower (<inline-formula id="inf2">
<mml:math id="m2">
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>&#x3c;</mml:mo>
<mml:mn>0.001</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>) in NDR group than that in healthy normal group. In the regression analysis, the increased ODRs except micro venule and decreased ODR<sub>v</sub> were significantly correlated with the incidence of DM, and the C-statistic for discrimination DM with all ODR is 0.777 (95% CI 0.687-0.867, <inline-formula id="inf3">
<mml:math id="m3">
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>&#x3c;</mml:mo>
<mml:mn>0.001</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>).</p>
<p>
<bold>Conclusion:</bold> A computational method to extract the retinal vascular oxygen-saturation-related optical density ratios (ODRs) with single color fundus photography was developed, and increased ODRs and decreased ODR<sub>v</sub> of retinal vessels could be new potential image biomarkers of DM.</p>
</abstract>
<kwd-group>
<kwd>fundus photography</kwd>
<kwd>diabetes mellitus</kwd>
<kwd>retina vessel segmentation</kwd>
<kwd>oxygen saturation level</kwd>
<kwd>light reflection analysis</kwd>
</kwd-group>
<contract-num rid="cn001">82230033</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Basic and Applied Basic Research Foundation of Guangdong Province<named-content content-type="fundref-id">10.13039/501100021171</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>subtitle</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>The eye is a structurally advanced optical organ with a complex vascular network. The maintenance of retinal function is critically dependent on the normal functioning of the blood-retinal barrier (<xref ref-type="bibr" rid="B16">Kaur et al., 2008</xref>; <xref ref-type="bibr" rid="B22">O&#x2019;Leary and Campbell, 2023</xref>). Fundus diseases and related systematic diseases can cause functional changes in the fundus such as ischemia and hypoxia, which can damage the blood-retinal barrier, leading to retinal vascular permeability changes, hemorrhage, exudation, neovascularization, and other lesions (<xref ref-type="bibr" rid="B25">Pournaras et al., 2008</xref>; <xref ref-type="bibr" rid="B1">Ascunce et al., 2023</xref>; <xref ref-type="bibr" rid="B21">Monickaraj et al., 2023</xref>). Diabetes mellitus (DM) is a common endocrine metabolic disease with its microvascular complications in the eye that can result in diabetic retinopathy (DR), which is the leading cause of blindness in working-age people (<xref ref-type="bibr" rid="B4">Bourne et al., 2021</xref>; <xref ref-type="bibr" rid="B28">Steinmetz et al., 2021</xref>). Hypoxia is considered to be the core pathogenesis of DR besides of hyperglycemia in retinal blood vessels caused by DM (<xref ref-type="bibr" rid="B10">Hardarson, 2013</xref>). Hypoxia along with hyperglycemia stimulate vascular endothelium and eventually lead to vascular endothelial cell dysfunction, which in turn leads to the occurrence of DR. (<xref ref-type="bibr" rid="B12">Hardarson and Stef&#xe1;nsson, 2012</xref>; <xref ref-type="bibr" rid="B17">Khoobehi et al., 2013</xref>). Therefore, it is equally important to detect retinal oxygen saturation as well as blood glucose in DM patients, which can help to prompt the potential occurrence of DR and avoid further visual impairment.</p>
<p>Retinal vessel is the only vascular system in the body that can be observed <italic>in vivo</italic> (<xref ref-type="bibr" rid="B9">Hanssen et al., 2022</xref>), and non-invasive imaging technique is the first choice for retinal vascular oxygen saturation measurement. Nevertheless, there are only limited imaging instruments available to measure retinal oxygen saturation, in which dual-wavelength retinal oximetry is a promising technique. By measuring the light of different wavelengths reflected from the eye, it takes advantage of the light absorption variations between oxyhemoglobin and hemoglobin, and a calculation can be made that correlates directly to the retinal vascular oxygenation (<xref ref-type="bibr" rid="B3">Beach, 2014</xref>; <xref ref-type="bibr" rid="B13">Jeppesen and Bek, 2019</xref>; <xref ref-type="bibr" rid="B6">Garg et al., 2021</xref>). Previous studies using retinal oximetry have found that the oxygen saturation of retinal vessels in DR is significantly higher than that in normal subjects, and increases with the severity of DR (<xref ref-type="bibr" rid="B12">Hardarson and Stef&#xe1;nsson, 2012</xref>; <xref ref-type="bibr" rid="B17">Khoobehi et al., 2013</xref>; <xref ref-type="bibr" rid="B14">J&#xf8;rgensen and Bek, 2014</xref>). Retinal oximetry has also been used to monitor retinal oxygen saturation in other eye diseases such as central retinal vein occlusion (CRVO) and glaucoma, showing varying degrees of increase in retinal oxygen saturation (<xref ref-type="bibr" rid="B27">Stef&#xe1;nsson et al., 2019</xref>). However, despite its potential, retinal oximetry is not widely used in ophthalmology clinics due to its recent commercialization.</p>
<p>Traditional color fundus cameras are the most commonly used equipment for fundus examination and disease screening (<xref ref-type="bibr" rid="B15">Karlsson et al., 2021</xref>). Their broad-spectrum cameras use complementary metal-oxide semiconductor (CMOS) or charge couple device (CCD) photoreceptors covered with red-green-blue (RGB) filters (<xref ref-type="bibr" rid="B20">Malvar et al., 2004</xref>). Thus, oxygen-sensitive and insensitive wavelengths reflected from retina vessels, which corresponds to different oxyhemoglobin and hemoglobin light absorptions, are generally received in the red and green channels, respectively, allowing for the estimation of blood oxygen function by extracting light absorption information from these channels.</p>
<p>In this study, we aim to develop a computational method for analyzing oxygen-saturation-related functional parameters with traditional color fundus photography based on precise vessel segmentation and light absorption analysis, providing an easy-to-apply image analysis algorithm for traditional color fundus cameras. With that, we also explore the characteristic alterations of retinal vascular oxygen function in type 2 DM patients to look for new potential image biomarkers for the monitoring of DM.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>2 Methods</title>
<sec id="s2-1">
<title>2.1 Ethics</title>
<p>This was a retrospective observational study. The project underwent a formal administrative review and was determined to be methodologically validated according to the institutional policy of Zhongshan Ophthalmic Center, Sun Yat-sen University. Therefore, this study was considered not to be a human subject&#x2019;s study, but the study was still reviewed by Institutional Review Board to avoid information leakage during data processing (protocol number: 2017KYPJ104).</p>
</sec>
<sec id="s2-2">
<title>2.2 Population</title>
<p>We included 50 patients with type 2 diabetes mellitus (DM) and a normal group of 50 age- and sex-matched healthy normal subjects between 1 January 2019 and 15 May 2021. All the subjects were adults. We extracted the age and sex information of the subjects from the medical records for intergroup matching and determined whether the subjects are patients with type 2 DM or not. To assess the existence of diabetic retinopathy, standard seven-fields fundus photographs were obtained with a mydriasis-free digital fundus camera (RetiCam 3100, SYSEYE, China). Patients with clinically detectable retinopathy, or with a history of ocular disease, inflammation, trauma, or any intraocular surgery were excluded. Further exclusion criteria include related systemic diseases, such as Alzheimer&#x2019;s disease, hypertension or lung disease. The healthy normal group should also meet the above exclusion criteria in addition to no diabetes.</p>
</sec>
<sec id="s2-3">
<title>2.3 Vessel segmentation and labeling</title>
<p>Only the 50&#xb0; fundus photography centered on the macula are analyzed. <xref ref-type="fig" rid="F1">Figure 1</xref> shows the flowchart for the processing of the region of interest (ROI) of retinal vessels. To extract the retinal vascular network, we employed an intelligent automatic vascular segmentation method, details of which are available in our earlier publication (<xref ref-type="bibr" rid="B33">Wang et al., 2021</xref>; <xref ref-type="bibr" rid="B32">2023</xref>). Briefly, the original fundus color photographs (<xref ref-type="fig" rid="F1">Figure 1A</xref>) were processed with an enhanced U-net by employing a multipath attention network model (MA-net) for improved vessel segmentation, achieving an area under the curve (AUC) of 0.9838 for segment accuracy (<xref ref-type="bibr" rid="B32">Wang et al., 2023</xref>). Blood vessel junctions on the obtained retinal vascular binarization network (<xref ref-type="fig" rid="F1">Figure 1B</xref>) were detected then through a convolution method on vessel skeleton, facilitating the vessel segments extraction (<xref ref-type="fig" rid="F1">Figure 1C</xref>). The arteriovenous labeling of the segmented vessels was further processed based on an intra-image regularization classifier (<xref ref-type="fig" rid="F1">Figure 1D</xref>) (<xref ref-type="bibr" rid="B34">Xu et al., 2017</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Region of interest extraction process. <bold>(A)</bold> Original color fundus photography. <bold>(B)</bold> Retinal vascular binarization network. <bold>(C)</bold> Retinal vessel segments map. <bold>(D)</bold> Arterial and venous labeling. <bold>(E,F)</bold> Green and red image channels extracted from the original fundus image. <bold>(G,H)</bold> Green and red channel of the vessel segments map. <bold>(I,J)</bold> Intravascular region of interest (IROI) and extravascular region of interest (EROI).</p>
</caption>
<graphic xlink:href="fcell-11-1195873-g001.tif"/>
</fig>
<p>To ensure the calculation of the oxygen-saturated-related functional parameter of retinal vessels, the red and green channels (<xref ref-type="fig" rid="F1">Figures 1E,F</xref>) composing the original fundus color photography were extracted through channel separation. By multiplying them with the binarized vessel segments map, oxygen-sensitive and insensitive wavelengths reflected from the retinal vascular areas were obtained (<xref ref-type="fig" rid="F1">Figures 1G,H</xref>), of which each vessel segment was marked as the intravascular regions of interest (IROI, <xref ref-type="fig" rid="F1">Figure 1I</xref>). To obtain the light reflection information of the retinal background around the vessel segment, a range of one vessel diameter is extended outward along the blood vessel segment outlines, which was marked as the extravascular region of interest (EROI, <xref ref-type="fig" rid="F1">Figure 1J</xref>).</p>
</sec>
<sec id="s2-4">
<title>2.4 Optical density ratio extraction</title>
<p>According to the EROI and IROI of blood vessels, the optical density (OD) values were calculated for every three pixels along the vascular central line (<xref ref-type="disp-formula" rid="e1">Formula 1</xref>), the red channel is used as the oxygen sensitive channel, and the green channel represents the oxygen insensitive channel, and the optical density ratio (ODR) of the two is defined as the blood oxygen-saturation-related parameter (<xref ref-type="disp-formula" rid="e2">Formula 2</xref>) (<xref ref-type="bibr" rid="B29">Tiedeman et al., 1998</xref>; <xref ref-type="bibr" rid="B2">Beach et al., 1999</xref>).<disp-formula id="e1">
<mml:math id="m4">
<mml:mrow>
<mml:mtable columnalign="center">
<mml:mtr>
<mml:mtd>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>D</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">log</mml:mi>
<mml:mn>10</mml:mn>
</mml:msub>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>O</mml:mi>
<mml:mrow>
<mml:mi>E</mml:mi>
<mml:mi>R</mml:mi>
<mml:mi>O</mml:mi>
<mml:mi>I</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>O</mml:mi>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mi>R</mml:mi>
<mml:mi>O</mml:mi>
<mml:mi>I</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:math>
<label>(1)</label>
</disp-formula>
<disp-formula id="e2">
<mml:math id="m5">
<mml:mrow>
<mml:mtable columnalign="center">
<mml:mtr>
<mml:mtd>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>D</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>d</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>D</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>g</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:math>
<label>(2)</label>
</disp-formula>
</p>
<p>In order to study the differences of different types of blood vessels, all branch vessels output ODR according to the labeling of arteries and veins, and distinguish between main and micro vessels referring to the setting of commercial retinal oximeter (<xref ref-type="bibr" rid="B26">Stef&#xe1;nsson et al., 2017</xref>), i.e., &#x2265;6pixel diameter (1pixel&#x2248;12.69&#xa0;&#x3bc;m in this study) was defined as main vessels and &#x3c;6pixel diameter was defined as micro vessels. Finally, ODR outputs the results according to all vessels (All), all arteriole (A), main arteriole (main A), micro arteriole (mic A), all venule (V), main venule (main V), and micro venule (mic V).</p>
<p>In addition to the ODR of each vascular subgroup, we also average the absolute value of the difference of ODR between all adjacent blocks of pixels and define it as ODR variability (ODR<sub>v</sub>, <xref ref-type="disp-formula" rid="e3">Formula 3</xref>).<disp-formula id="e3">
<mml:math id="m6">
<mml:mrow>
<mml:mtable columnalign="center">
<mml:mtr>
<mml:mtd>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>D</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
<mml:mi>v</mml:mi>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mo>&#x2211;</mml:mo>
<mml:mrow>
<mml:mfenced open="|" close="|" separators="|">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>D</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
<mml:mi>n</mml:mi>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>D</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
</mml:math>
<label>(3)</label>
</disp-formula>
</p>
</sec>
<sec id="s2-5">
<title>2.5 Statistical analysis</title>
<p>Student&#x2019;s t-test or chi-square test used to compare the differences between Normal and DM groups. All data were recorded as mean &#xb1; standard deviation (SD). Data distribution was analyzed by the Kolmogorov&#x2013;Smirnov test to determine normally distributed data (<inline-formula id="inf4">
<mml:math id="m7">
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>&#x3e;</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mn>0.05</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>). Logistics regression was used to analyze the relationship between ODR and DM in each vascular subgroup and to generate ROC curve to evaluate the diagnostic efficiency of retinal vascular function parameters. All statistical analyses were performed using SPSS software (25.0; IBM Corporation, Armonk, NY). GraphPad Prism 9.0 was used for data visualization.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<p>There is no difference in the age and sex between the 50 healthy volunteers in Normal group and the 50 patients in DM group (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Clinical parameters and ODR of study subjects.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="left">Normal</th>
<th align="left">DM</th>
<th align="left">T-statistic</th>
<th align="center">
<italic>p</italic> value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">No, of subject</td>
<td align="left">50</td>
<td align="left">50</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Age, yrs</td>
<td align="left">43.4 (4.5)</td>
<td align="left">43.9 (4.8)</td>
<td align="left">&#x2212;0.555</td>
<td align="left">0.58</td>
</tr>
<tr>
<td align="left">Sex, female, no (%)</td>
<td align="left">23 (46%)</td>
<td align="left">24 (48%)</td>
<td align="left">NA</td>
<td align="left">0.55</td>
</tr>
<tr>
<td align="left">Duration of diabetes, yrs</td>
<td align="left">/</td>
<td align="left">4.16 (4.03)</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Fasting plasma glucose, mmol/L</td>
<td align="left">/</td>
<td align="left">8.89 (4.55)</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Optical density ratio, ODR</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">All vessels</td>
<td align="left">0.711 (0.060)</td>
<td align="left">0.754 (0.082)</td>
<td align="left">&#x2212;3.037</td>
<td align="left">0.03</td>
</tr>
<tr>
<td align="left">All arteriole</td>
<td align="left">0.713 (0.057)</td>
<td align="left">0.755 (0.083)</td>
<td align="left">&#x2212;2.997</td>
<td align="left">0.04</td>
</tr>
<tr>
<td align="left">All venule</td>
<td align="left">0.709 (0.063)</td>
<td align="left">0.754 (0.082)</td>
<td align="left">&#x2212;3.037</td>
<td align="left">0.03</td>
</tr>
<tr>
<td align="left">Main arteriole</td>
<td align="left">0.728 (0.056)</td>
<td align="left">0.773 (0.083)</td>
<td align="left">&#x2212;3.199</td>
<td align="left">0.02</td>
</tr>
<tr>
<td align="left">Main venule</td>
<td align="left">0.717 (0.058)</td>
<td align="left">0.761 (0.082)</td>
<td align="left">&#x2212;3.092</td>
<td align="left">0.03</td>
</tr>
<tr>
<td align="left">Micro arteriole</td>
<td align="left">0.634 (0.068)</td>
<td align="left">0.672 (0.096)</td>
<td align="left">&#x2212;2.263</td>
<td align="left">0.026</td>
</tr>
<tr>
<td align="left">Micro venule</td>
<td align="left">0.599 (0.082)</td>
<td align="left">0.627 (0.117)</td>
<td align="left">&#x2212;1.405</td>
<td align="left">0.164</td>
</tr>
<tr>
<td align="left">Variability (ODR<sub>v</sub>)</td>
<td align="left">0.273 (0.025)</td>
<td align="left">0.236 (0.059)</td>
<td align="left">3.915</td>
<td align="left">&#x3c;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>a. Student&#x2019;s t-test or chi-square test used to compare difference between groups.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>
<xref ref-type="table" rid="T1">Table 1</xref> alsodemonstrates the ODR for all vascular subgroups, ODR<sub>v</sub>, as well as the t-statistic and <italic>p</italic>-values. In both healthy normal group and DM group, A ODR is higher than V ODR (mean &#xb1; SD, A vs. V, Normal: 0.713 &#xb1; 0.057 vs. 0.708 &#xb1; 0.063; DM: 0.755 &#xb1; 0.083 vs. 0.754 &#xb1; 0.082), main A ODR is higher than main V ODR (Normal: 0.728 &#xb1; 0.056 vs. 0.717 &#xb1; 0.058; DM: 0.773 &#xb1; 0.083 vs. 0.761 &#xb1; 0.082) and micro A is higher than micro V ODR (Normal: 0.634 &#xb1; 0.068 vs. 0.599 &#xb1; 0.082; DM: 0.672 &#xb1; 0.096 vs. 0.627 &#xb1; 0.117), which means that ODR is positively correlated with blood oxygen saturation. Compared to Normal group, ODR is significantly increased in all vascular subgroups except micro venular in DM group (<inline-formula id="inf5">
<mml:math id="m8">
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>&#x3c;</mml:mo>
<mml:mn>0.05</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>, respectively). ODR<sub>v</sub> is significantly decreased in DM group (<inline-formula id="inf6">
<mml:math id="m9">
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>&#x3c;</mml:mo>
<mml:mn>0.001</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>).</p>
<p>As shown in the logistics regression results in <xref ref-type="table" rid="T2">Table 2</xref>, higher ODRs are significantly associated with the occurrence of DM, especially in main A (OR 1.953, 95% CI 1.252-3.046) and main V (OR 1.908, 95% CI 1.227-2.968), and also in micro A (OR 1.604, 1.047-2.455). While Lower ODR<sub>v</sub> (OR 0.381, 95% CI 0.210-0.693) is significantly associated with the occurrence of DM. The C-statistic for the discrimination of DM from the healthy normal group combining all the acquired oxygen-saturation-related functional parameters is 0.777 (95% CI 0.687-0.867, <inline-formula id="inf7">
<mml:math id="m10">
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>&#x3c;</mml:mo>
<mml:mn>0.001</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Variables in the equation of the logistics regression.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center"/>
<th rowspan="2" align="center">OR</th>
<th colspan="2" align="center">95% CI</th>
<th rowspan="2" align="center">
<italic>p</italic> value</th>
</tr>
<tr>
<th align="center">Lower</th>
<th align="center">Upper</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">All vessels</td>
<td align="center">1.885</td>
<td align="center">1.214</td>
<td align="center">2.925</td>
<td align="center">0.005</td>
</tr>
<tr>
<td align="center">All arteriole</td>
<td align="center">1.863</td>
<td align="center">1.201</td>
<td align="center">2.891</td>
<td align="center">0.006</td>
</tr>
<tr>
<td align="center">All venule</td>
<td align="center">1.884</td>
<td align="center">1.215</td>
<td align="center">2.923</td>
<td align="center">0.005</td>
</tr>
<tr>
<td align="center">Main arteriole</td>
<td align="center">1.953</td>
<td align="center">1.252</td>
<td align="center">3.046</td>
<td align="center">0.020</td>
</tr>
<tr>
<td align="center">Main venule</td>
<td align="center">1.908</td>
<td align="center">1.227</td>
<td align="center">2.968</td>
<td align="center">0.004</td>
</tr>
<tr>
<td align="center">Micro arteriole</td>
<td align="center">1.604</td>
<td align="center">1.047</td>
<td align="center">2.455</td>
<td align="center">0.030</td>
</tr>
<tr>
<td align="center">Micro venule</td>
<td align="center">1.334</td>
<td align="center">0.889</td>
<td align="center">2.002</td>
<td align="center">0.166</td>
</tr>
<tr>
<td align="center">Variability</td>
<td align="center">0.381</td>
<td align="center">0.210</td>
<td align="center">0.693</td>
<td align="center">0.002</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>a. Logical regression was used to analyze the relationship between ODR, and DM, in each vascular subgroup and variability.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>ROC curves of predictive discrimination for DM.</p>
</caption>
<graphic xlink:href="fcell-11-1195873-g002.tif"/>
</fig>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>In this study, we present a computational approach for extracting oxygen-saturation-related functional parameters through precise vascular segmentation and light reflection channel analysis using single traditional color fundus photography. By applying this method to the comprehensive analysis of the fundus images acquired from normal individuals and patients with type 2 diabetes, we revealed that the retinal vascular ODRs were increased while the ODR variability was reduced significantly in DM patients, providing new potential image biomarkers for the management of DM.</p>
<p>The successful extraction of retinal vascular ODRs with color fundus photography offers a new protocol for retinal vascular function evaluation, providing additional quantitative functional information based on the most commonly used fundus imaging tools in clinical settings. Compared to the current existed retinal oximetry, which only reveals oxygen saturation level in main retinal vessels and requires subjects to withstand long light exposure time (<xref ref-type="bibr" rid="B10">Hardarson, 2013</xref>), our method achieves information in microvascular level without any additional hardware implementation, which ensures its convenience and accessibility with greatly reduced cost. These advantages suggest extensive potential application value in the diagnosis and screening of retinal diseases.</p>
<p>In our study, we have shown that the increase of proposed oxygen-saturation-related ODRs were statistically significant at the stage of DM, which could be related to the stronger affinity of glycosylated hemoglobin to oxygen in DM (<xref ref-type="bibr" rid="B8">Graham et al., 1980</xref>; <xref ref-type="bibr" rid="B30">van Kampen and Zijlstra, 1983</xref>). Indeed, former studies using retinal oximetry have found obvious increase in retinal oxygen saturation level during DR, especially in proliferative DR, but no significant change was shown in DM stage before (<xref ref-type="bibr" rid="B17">Khoobehi et al., 2013</xref>). This indicates that our newly proposed ODRs might be more sensitive parameters than that of commercial retinal oximetry in finding alterations in blood oxygen function. Moreover, our exploration of ODR in the microvascular groups revealing significant increase in micro arterioles of DM patients further proves the high sensitivity of our method.</p>
<p>We have proposed and analyzed the ODR variability for the first time on the basis of extracted ODR of the full retinal vascular network and found it to be significantly decreased in DM patients compared to normal subjects. While glycosylated hemoglobin has higher affinity to oxygen (<xref ref-type="bibr" rid="B8">Graham et al., 1980</xref>), it damps the oxygen-release capacity (<xref ref-type="bibr" rid="B5">Ditzel, 1972</xref>) of retinal blood, results in reduced oxygen saturation variations. Studies have also found that the retinal blood flow velocity increases in DM patients (<xref ref-type="bibr" rid="B18">Landa et al., 2011</xref>), meaning less oxygen release time of blood in retinal vessels, further reduced the ODR variability.</p>
<p>Our method suffers limited retinal vessel resolution and imaging depth due to the physical nature of fundus photography. Only the superficial retinal vessels can be analyzed without 3-dimensional (3D) illustration. The same limitations also exist in current commercial retinal oximetry. Recently, visible-light optical coherence tomography based techniques for retinal oxygen saturation measurement have been gradually proposed (<xref ref-type="bibr" rid="B23">Pi et al., 2020</xref>; <xref ref-type="bibr" rid="B24">Poddar and Basu, 2020</xref>), achieving high resolution 3D imaging of retinal vascular oxygen function information (<xref ref-type="bibr" rid="B23">Pi et al., 2020</xref>), although most of these studies are still in laboratorial stage.</p>
<p>Our attempt to distinguish DM from normal subjects with all the extracted functional ODR parameters showed a relative low C statistic result (AUC &#x3d; 0.777), which is not sufficient for DM diagnosis or screening. Since our previous study found that the morphological parameters of retinal vessels in DM patients also changed significantly (<xref ref-type="bibr" rid="B19">Li et al., 2021</xref>), further combining functional and morphological parameters of retinal blood vessels and multi-center studies or follow-up studies may help us better understand the changes in retinal blood vessel characteristics during the occurrence and development of DM and even DR, so as to diagnose DM or DR More accurately. Furthermore, applying our method to other eye diseases related to retinal vascular oxygen function alterations such as glaucoma (<xref ref-type="bibr" rid="B31">Vandewalle et al., 2014</xref>), central retinal vein occlusion (<xref ref-type="bibr" rid="B11">Hardarson and Stef&#xe1;nsson, 2010</xref>), age-related macular degeneration (<xref ref-type="bibr" rid="B7">Geirsdottir et al., 2014</xref>), etc. in the future would further demonstrate the reliability and universality of our method.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article are available from the corresponding authors upon reasonable request.</p>
</sec>
<sec id="s6">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by Institutional Review Board of Zhongshan Ophthalmic Center, Sun Yat-sen University. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>JZ and ZL: Conceptualization, methodology, software, and writing&#x2014;original draft. GW and YH: methodology and writing&#x2014;review and editing. KF, YL, and JL: Investigation and data collection and writing&#x2014;review and editing. JY and PX: Conceptualization, writing&#x2014;review and editing, and supervision. All authors read and approved the final manuscript. All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (Nos. 82230033 and 82271133), the Department of Science and Technology of Guangdong Province (Nos. 2021TX06Y127 and 2021TQ06Y137), and the Basic and Applied Basic Research Foundation of Guangdong Province (No. 2022A1515011486).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ascunce</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dhodapkar</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hafler</surname>
<given-names>B. P.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Innate immune biology in age-related macular degeneration</article-title>. <source>Front. Cell Dev. Biol</source>. <volume>11</volume>, <fpage>1118524</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2023.1118524</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beach</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Schwenzer</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Srinivas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tiedeman</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Oximetry of retinal vessels by dual-wavelength imaging: Calibration and influence of pigmentation</article-title>. <source>J. Appl. Physiol</source>. <volume>86</volume>, <fpage>748</fpage>&#x2013;<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1999.86.2.748</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beach</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Pathway to retinal oximetry</article-title>. <source>Trans. Vis. Sci. Tech</source>. <volume>3</volume>, <fpage>2</fpage>. <pub-id pub-id-type="doi">10.1167/tvst.3.5.2</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourne</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Steinmetz</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Flaxman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Briant</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Resnikoff</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Trends in prevalence of blindness and distance and near vision impairment over 30 years: An analysis for the global burden of disease study</article-title>. <source>Lancet Glob. Health</source> <volume>9</volume>, <fpage>e130</fpage>&#x2013;<lpage>e143</lpage>. <pub-id pub-id-type="doi">10.1016/S2214-109X(20)30425-3</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ditzel</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1972</year>). <article-title>Impaired oxygen release caused by alterations of the metabolism in the erythrocytes in diabetes</article-title>. <source>Lancet</source> <volume>1</volume>, <fpage>721</fpage>&#x2013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(72)90233-4</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garg</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lando</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>D. L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Advances in retinal oximetry</article-title>. <source>Transl. Vis. Sci. Technol</source>. <volume>10</volume>, <fpage>5</fpage>. <pub-id pub-id-type="doi">10.1167/tvst.10.2.5</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geirsdottir</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hardarson</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Olafsdottir</surname>
<given-names>O. B.</given-names>
</name>
<name>
<surname>Stef&#xe1;nsson</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Retinal oxygen metabolism in exudative age-related macular degeneration</article-title>. <source>Acta Ophthalmol</source>. <volume>92</volume>, <fpage>27</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1111/aos.12294</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graham</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Ryall</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Wise</surname>
<given-names>P. H.</given-names>
</name>
</person-group> (<year>1980</year>). <article-title>Glycosylated haemoglobin and relative polycythaemia in diabetes mellitus</article-title>. <source>Diabetologia</source> <volume>18</volume>, <fpage>205</fpage>&#x2013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1007/BF00251917</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanssen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Streese</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vilser</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Retinal vessel diameters and function in cardiovascular risk and disease</article-title>. <source>Prog. Retin Eye Res</source>. <volume>91</volume>, <fpage>101095</fpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2022.101095</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hardarson</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Retinal oximetry</article-title>. <source>Acta Ophthalmol</source>. <volume>91</volume>, <fpage>1</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1111/aos.12086</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hardarson</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Stef&#xe1;nsson</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Oxygen saturation in central retinal vein occlusion</article-title>. <source>Am. J. Ophthalmol</source>. <volume>150</volume>, <fpage>871</fpage>&#x2013;<lpage>875</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajo.2010.06.020</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hardarson</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Stef&#xe1;nsson</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Retinal oxygen saturation is altered in diabetic retinopathy</article-title>. <source>Br. J. Ophthalmol</source>. <volume>96</volume>, <fpage>560</fpage>&#x2013;<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1136/bjophthalmol-2011-300640</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeppesen</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Bek</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The retinal oxygen saturation measured by dual wavelength oximetry in larger retinal vessels is influenced by the linear velocity of the blood</article-title>. <source>Curr. Eye Res</source>. <volume>44</volume>, <fpage>46</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1080/02713683.2018.1524015</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>J&#xf8;rgensen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bek</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Increasing oxygen saturation in larger retinal vessels after photocoagulation for diabetic retinopathy</article-title>. <source>Invest. Ophthalmol. Vis. Sci</source>. <volume>55</volume>, <fpage>5365</fpage>&#x2013;<lpage>5369</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.14-14811</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karlsson</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Jonsson</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Hardarson</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Olafsdottir</surname>
<given-names>O. B.</given-names>
</name>
<name>
<surname>Halldorsson</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Stefansson</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Automatic fundus image quality assessment on a continuous scale</article-title>. <source>Comput. Biol. Med</source>. <volume>129</volume>, <fpage>104114</fpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2020.104114</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaur</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Foulds</surname>
<given-names>W. S.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>E. A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Blood-retinal barrier in hypoxic ischaemic conditions: Basic concepts, clinical features and management</article-title>. <source>Prog. Retin Eye Res</source>. <volume>27</volume>, <fpage>622</fpage>&#x2013;<lpage>647</lpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2008.09.003</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khoobehi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Firn</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Reinoso</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Beach</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Retinal arterial and venous oxygen saturation is altered in diabetic patients</article-title>. <source>Invest. Ophthalmol. Vis. Sci</source>. <volume>54</volume>, <fpage>7103</fpage>&#x2013;<lpage>7106</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.13-12723</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landa</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Amde</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Haileselassie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>R. B.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Cilioretinal arteries in diabetic eyes are associated with increased retinal blood flow velocity and occurrence of diabetic macular edema</article-title>. <source>Retina</source> <volume>31</volume>, <fpage>304</fpage>&#x2013;<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1097/IAE.0b013e3181e91108</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Retinal vascular geometry detection as a biomarker in diabetes mellitus</article-title>. <source>Eur. J. Ophthalmol</source>. <volume>112067212110334</volume>, <fpage>1710</fpage>&#x2013;<lpage>1719</lpage>. <pub-id pub-id-type="doi">10.1177/11206721211033488</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Malvar</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L.-W.</given-names>
</name>
<name>
<surname>Cutler</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2004</year>). &#x201c;<article-title>High-quality linear interpolation for demosaicing of Bayer-patterned color images</article-title>,&#x201d; in <conf-name>2004 IEEE International Conference on Acoustics, Speech, and Signal Processing</conf-name>, <conf-loc>Montreal, Canada</conf-loc>, <conf-date>May 2004</conf-date> (<publisher-name>IEEE</publisher-name>), <fpage>485</fpage>&#x2013;<lpage>488</lpage>.</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monickaraj</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Acosta</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cabrera</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Transcriptomic profiling reveals chemokine CXCL1 as a mediator for neutrophil recruitment associated with blood-retinal barrier alteration in diabetic retinopathy</article-title>. <source>Diabetes</source>, <fpage>db220619</fpage>. <pub-id pub-id-type="doi">10.2337/db22-0619</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Leary</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The blood-retina barrier in health and disease</article-title>. <source>FEBS J</source>. <volume>290</volume>, <fpage>878</fpage>&#x2013;<lpage>891</lpage>. <pub-id pub-id-type="doi">10.1111/febs.16330</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hormel</surname>
<given-names>T. T.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cepurna</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>J. C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Retinal capillary oximetry with visible light optical coherence tomography</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>117</volume>, <fpage>11658</fpage>&#x2013;<lpage>11666</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1918546117</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poddar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Characterization and oxygen saturation study of human retinal blood vessels evaluated by spectroscopic Optical Coherence Tomography Angiography</article-title>. <source>Opt. Laser Technol</source>. <volume>122</volume>, <fpage>105886</fpage>. <pub-id pub-id-type="doi">10.1016/j.optlastec.2019.105886</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pournaras</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Rungger-Br&#xe4;ndle</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Riva</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Hardarson</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Stefansson</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Regulation of retinal blood flow in health and disease</article-title>. <source>Prog. Retin Eye Res</source>. <volume>27</volume>, <fpage>284</fpage>&#x2013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2008.02.002</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stef&#xe1;nsson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Olafsdottir</surname>
<given-names>O. B.</given-names>
</name>
<name>
<surname>Einarsdottir</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Eliasdottir</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Eysteinsson</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vehmeijer</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Retinal oximetry discovers novel biomarkers in retinal and brain diseases</article-title>. <source>Invest. Ophthalmol. Vis. Sci</source>. <volume>58</volume>, <fpage>BIO227</fpage>&#x2013;<lpage>BIO233</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.17-21776</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stef&#xe1;nsson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Olafsdottir</surname>
<given-names>O. B.</given-names>
</name>
<name>
<surname>Eliasdottir</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Vehmeijer</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Einarsdottir</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Bek</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Retinal oximetry: Metabolic imaging for diseases of the retina and brain</article-title>. <source>Prog. Retin. Eye Res</source>. <volume>70</volume>, <fpage>1</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.preteyeres.2019.04.001</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steinmetz</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Bourne</surname>
<given-names>R. R. A.</given-names>
</name>
<name>
<surname>Briant</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Flaxman</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>H. R. B.</given-names>
</name>
<name>
<surname>Jonas</surname>
<given-names>J. B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The right to sight: An analysis for the global burden of disease study</article-title>. <source>Lancet Glob. Health</source> <volume>9</volume>, <fpage>e144</fpage>&#x2013;<lpage>e160</lpage>. <pub-id pub-id-type="doi">10.1016/S2214-109X(20)30489-7</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiedeman</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Kirk</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Srinivas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Beach</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Retinal oxygen consumption during hyperglycemia in patients with diabetes without retinopathy</article-title>. <source>Ophthalmology</source> <volume>105</volume>, <fpage>31</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/s0161-6420(98)71029-1</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Kampen</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Zijlstra</surname>
<given-names>W. G.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>Spectrophotometry of hemoglobin and hemoglobin derivatives</article-title>. <source>Adv. Clin. Chem</source>. <volume>23</volume>, <fpage>199</fpage>&#x2013;<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1016/s0065-2423(08)60401-1</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vandewalle</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Abeg&#xe3;o Pinto</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Olafsdottir</surname>
<given-names>O. B.</given-names>
</name>
<name>
<surname>De Clerck</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stalmans</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Van Calster</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Oximetry in glaucoma: Correlation of metabolic change with structural and functional damage</article-title>. <source>Acta Ophthalmol</source>. <volume>92</volume>, <fpage>105</fpage>&#x2013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1111/aos.12011</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Automatic vessel crossing and bifurcation detection based on multi-attention network vessel segmentation and directed graph search</article-title>. <source>Comput. Biol. Med</source>. <volume>155</volume>, <fpage>106647</fpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2023.106647</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>A novel multiple subdivision-based algorithm for quantitative assessment of retinal vascular tortuosity</article-title>. <source>Exp. Biol. Med. (Maywood)</source> <volume>246</volume>, <fpage>2222</fpage>&#x2013;<lpage>2229</lpage>. <pub-id pub-id-type="doi">10.1177/15353702211032898</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Abr&#xe0;moff</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>An improved arteriovenous classification method for the early diagnostics of various diseases in retinal image</article-title>. <source>Comput. Methods Programs Biomed</source>. <volume>141</volume>, <fpage>3</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmpb.2017.01.007</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>